SPARTAN: Alterations in Gait, Strength, and Power After Ruck Marching

Sponsor
State University of New York at Buffalo (Other)
Overall Status
Recruiting
CT.gov ID
NCT05309603
Collaborator
(none)
20
1
3
8.4
2.4

Study Details

Study Description

Brief Summary

The purpose of this study is to determine change in injury risk and performance variables in males and females after walking unloaded and carrying a load with two different distributions (high-pack placement and mid-pack placement) to identify differences in injury risk

Condition or Disease Intervention/Treatment Phase
  • Other: Loaded Walking High
  • Other: Loaded Walking Mid
  • Other: Walking
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Alterations in Gait, Strength, and Power After Ruck Marching
Actual Study Start Date :
Mar 21, 2022
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Unloaded Walking

Walking on a treadmill without wearing a pack

Other: Walking
Walking three miles on a treadmill at a self-selected speed

Experimental: Loaded Walking High

Walking on a treadmill while wearing a 30% body mass load with the weight placed at the high-back

Other: Loaded Walking High
Walking three miles on a treadmill at a self-selected speed while wearing a backpack with weight carried high on the back

Experimental: Loaded Walking Mid

Walking on a treadmill while wearing a 30% body mass load with the weight placed at the mid-back

Other: Loaded Walking Mid
Walking three miles on a treadmill at a self-selected speed while wearing a backpack with weight carried on the mid-back

Outcome Measures

Primary Outcome Measures

  1. Change in Oxygen Consumption [Upon completion of 3 miles of walking, an average of 45 minutes]

    Oxygen consumption will be measured using indirect calorimetry

  2. Increased muscular jerk [Upon completion of 3 miles of walking, an average of 45 minutes]

    Jerk will be measured using accelerometers placed at the torso and ankle

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 39 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthy, physically active individuals

  • 18-39 years old

Exclusion Criteria:
  • History of musculoskeletal injury within the last six months or still under a physicians care for an injury occurring more than six month prior

  • History of spinal disc injury

  • History of cardiovascular, metabolic, respiratory, neural, or renal disease

  • No previous history or education of completing resistance exercise

  • Hypertensive or tachycardic during the screening visit (SBP > 139 mmHg, DBP > 89 mmHg, heart rate > 100 bpm)

  • Taking medication or supplements with a known side effect of affecting physiologic responses to exercise (e.g., beta blockers, omega-3 fatty acids, statins, aspirin)

  • Any form of tobacco or nicotine use

  • A positive pregnancy test at any point in the study

  • Study physician discretion based on any other medical condition or medication

  • Gastrointestinal disease or previous surgery prohibiting internal body temperature pill use. Subjects who have any contraindication to internal body temperature pill ingestion will be given the option to insert the pill rectally (as a suppository) or use a rectal probe.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University at Buffalo Buffalo New York United States 14214

Sponsors and Collaborators

  • State University of New York at Buffalo

Investigators

  • Principal Investigator: Riana Pryor, PhD, University at Buffalo

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Riana Pryor, Assistant Professor, State University of New York at Buffalo
ClinicalTrials.gov Identifier:
NCT05309603
Other Study ID Numbers:
  • STUDY00006175
First Posted:
Apr 4, 2022
Last Update Posted:
Apr 4, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 4, 2022